Categories
Cancer Treatment Claims & Critical Analysis Cancer Treatment Research & Critical Analysis Patient-Doctor Communication

Why Oncologists Are Cautious: What Mainstream Cancer Centers Say in 2026

At Courage Against Cancer (CAC), we believe patients deserve evidence-based answers to the pillar article’s primary question — not dismissal, and not hype. Oncologist caution around fenbendazole in 2026 is rooted in specific clinical and regulatory reasoning, not ignorance of the research.

Categories
Cancer Treatment Claims & Critical Analysis Fenbendazole Fenbendazole and Cancer

Real Risks and Safety Concerns of Self-Medicating With Fenbendazole

At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the most pressing question surrounding fenbendazole and colorectal cancer: Is it actually safe to use on your own? Fenbendazole — a veterinary antiparasitic drug — has gone viral as a potential cancer-fi…

Categories
Cancer Treatment Claims & Critical Analysis Evaluating Cancer Treatment Claims Fenbendazole and Cancer

Why Oncologists and Cancer Organizations Do Not Currently Recommend Fenbendazole

At Courage Against Cancer (CAC), we believe every cancer patient deserves honest, evidence-based answers to the most pressing questions — including this one. Fenbendazole, a veterinary anthelmintic, has generated significant interest through anecdotal stories, but mainstream oncology has not yet endorsed it.